Bridgewater Associates’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bridgewater Associates’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-28,537	Closed	-$533K	–	1081
2022 Q1	$533K	Buy	+28,537	New	+$513K	﹤0.01%	880

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bridgewater Associates's OCDX Position: Q2 2022 in Review

Bridgewater Associates sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 28,537 shares — an estimated $533K sold.

Bridgewater Associates first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $533K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Bridgewater Associates reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Bridgewater Associates sold 28,537 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $533K.
Bridgewater Associates first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
Bridgewater Associates's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $533K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Bridgewater Associates's 13F filing for Q2 2022, filed 11 Aug 2022.